allogeneic human umbilical cord-derived mesenchymal stem cells (Hebei Medical University)

N/A

Report date: 2025/03/14 16:24:11

Base Information

Drug Nameallogeneic human umbilical cord-derived mesenchymal stem cells (Hebei Medical University)
Drug Alias Namemesenchymal stem cell therapy (Hebei Medical University)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHebei Medical University
China Registration ClassN/A

Develop Information

Active CompaniesHebei Medical University
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A